Track the companies that matter to you. It's FREE! Click one of these fan favorites to get started: Apple; Google; Ford.

MAKO Surgical Increases Sales but Misses Estimates on Earnings

MAKO Surgical (Nasdaq: MAKO  ) reported earnings on May 7. Here are the numbers you need to know.

The 10-second takeaway
For the quarter ended March 31 (Q1), MAKO Surgical whiffed on revenues and missed expectations on earnings per share.

Compared to the prior-year quarter, revenue grew significantly and GAAP loss per share increased.

Margins improved across the board.

Revenue details
MAKO Surgical reported revenue of $19.6 million. The eight analysts polled by S&P Capital IQ looked for a top line of $23.6 million on the same basis. GAAP reported sales were 51% higher than the prior-year quarter's $13.0 million.

Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.

EPS details
EPS came in at -$0.28. The nine earnings estimates compiled by S&P Capital IQ forecast -$0.20 per share. GAAP EPS were -$0.28 for Q1 versus -$0.27 per share for the prior-year quarter.

Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.

Margin details
For the quarter, gross margin was 72.1%, 350 basis points better than the prior-year quarter. Operating margin was -59.9%, 2,490 basis points better than the prior-year quarter. Net margin was -59.7%, 2,470 basis points better than the prior-year quarter.

Looking ahead
Next quarter's average estimate for revenue is $27.7 million. On the bottom line, the average EPS estimate is -$0.22.

Next year's average estimate for revenue is $127.4 million. The average EPS estimate is -$0.56.

Investor sentiment
The stock has a four-star rating (out of five) at Motley Fool CAPS, with 911 members out of 943 rating the stock outperform, and 32 members rating it underperform. Among 240 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 230 give MAKO Surgical a green thumbs-up, and 10 give it a red thumbs-down.

Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on MAKO Surgical is outperform, with an average price target of $42.25.

Over the decades, small-cap stocks like MAKO Surgical have produced market-beating returns, provided they're value-priced and have solid businesses. Read about a pair of companies with a lock on their markets in "Too Small to Fail: 2 Small Caps the Government Won't Let Go Broke." Click here for instant access to this free report.

Seth Jayson had no position in any company mentioned here at the time of publication. You can view his stock holdings here. He is co-advisor of Motley Fool Hidden Gems, which provides new small-cap ideas every month, backed by a real-money portfolio. The Motley Fool owns shares of MAKO Surgical. Motley Fool newsletter services have recommended buying shares of MAKO Surgical. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Read/Post Comments (0) | Recommend This Article (7)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 1881809, ~/Articles/ArticleHandler.aspx, 3/30/2015 10:42:27 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...